INNITIUS key facts
as of Oct 2026- Developer of actionable diagnostic devices designed to improve women's health through the use of torsional waves.
- INNITIUS is valued at approximately $9.7M as of Oct 2026 (last reported valuation).
- It has raised $8.9M.
- Notable investors include European Innovation Council, Clave (Pamplona), Seed Capital Bizkaia, Clave Capital, Banco Santander — 17 tracked in total.
- Status: Privately Held (backing).
INNITIUS's last reported valuation, Sep 2023. Nothing priced has surfaced since.
- ·The complete investor list: 17 names
- ·Watch INNITIUS: the Monday email on marks, rounds and moves
INNITIUS funding rounds
No funding rounds for INNITIUS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs INNITIUS
17+INNITIUS valuation
INNITIUS's last reported valuation was $9.7 million in Sep 2023. No priced round, secondary trade or fund mark has surfaced since.
INNITIUS investors
17 investors are on record for INNITIUS, including European Innovation Council, Clave (Pamplona), Seed Capital Bizkaia and Clave Capital.
About INNITIUS
Developer of actionable diagnostic devices designed to improve women's health through the use of torsional waves. The company's devices utilize a patented intravaginal probe to transmit torsional waves for the diagnosis of conditions associated with changes in tissue consistency and threatened preterm labor events, enabling medical practitioners to detect false indications of premature birth.
- Sector
- Healthcare
- HQ
- Bilbao, Spain
- Founded
- 2018
- Employees
- 27
- Website
- innitius.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.